Cairo – February 10, 2025
Alameda Healthcare Group, a leading private healthcare provider in Egypt, has signed a Memorandum of Understanding (MoU) with Eva Pharma, a leading national pharmaceutical company in Egypt and the Middle East, aiming to strengthen collaboration in therapeutic sustainability and medical education. This joint effort seeks to improve the quality of healthcare in Egypt.
The MoU establishes a strategic partnership to ensure the continuous availability of essential treatments. It also outlines the organization of specialized medical, educational, and scientific programs for healthcare professionals, focusing on the optimal use of antibiotics and antifungals.
Neeraj Mishra, CEO of Alameda Healthcare Group, stated, “Signing the MoU is a significant strategic step aimed at providing high-quality healthcare services. It includes forming a joint task force comprising representatives from both parties to oversee the implementation of agreed-upon activities and hold regular meetings to develop execution plans.”
“This MoU serves as a strategic framework for a collaborative partnership designed to enhance the quality of healthcare in Egypt through continuous medical education, patient awareness initiatives, and the application of the latest medical guidelines to ensure best therapeutic practices.” He added
Abram Wagih, Egypt Cluster Head at EVA Pharma, remarked, “Today’s collaboration marks a new step towards building bridges between the medical community and the pharmaceutical manufacturing sector in Egypt, as we move towards a shared goal of advancing public health and improving the quality of medical care.”
Dr. Wagih further noted in a press statement that the cooperation will include launching patient awareness campaigns. Eva Pharma will sponsor these campaigns through Alameda’s platforms to raise awareness about the safe and effective use of antibiotics and antifungals, contributing to public health improvement. He emphasized the company’s commitment to providing the latest recommendations, guidelines, and treatment protocols to Alameda’s physicians and medical staff to ensure the application of best therapeutic practices in line with the latest medical standards.
“We believe that education and awareness are the two fundamental pillars for achieving better healthcare. This collaboration reflects our commitment to supporting Egypt’s healthcare system by adopting the best global practices.” He added.
Alameda is committed to expanding cooperation with various leading entities in the medical field, believing that strategic partnerships are the cornerstone for developing Egypt’s healthcare system. Through enhanced collaboration with pharmaceutical companies and research institutions, the group aims to provide the latest therapeutic solutions, support continuous medical education, and elevate the proficiency of medical personnel, thereby contributing to the improvement of healthcare service quality.
